Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 10.32% vs -0.62% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 1,529.63% vs -72.16% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is 88.89% vs 57.14% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is 200.00% vs -50.00% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of Tibet Aim Pharm., Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 8.96% vs 9.70% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 10.32% vs -0.62% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 134.04% vs -0.53% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 1,529.63% vs -72.16% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -33.92% vs 76.88% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 88.89% vs 57.14% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs 50.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 200.00% vs -50.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






